Home › Heart Valve Diseases › Illinois › Chicago
Heart Valve Diseases clinical trials in Chicago, IL
5 studies for Heart Valve Diseases are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EFS of the DUO System for Tricuspid Regurgitation
Recruiting
- Northwestern University, Chicago
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Recruiting
- Northwestern Memorial Hospital, Chicago
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
The TRICURE EFS Study
Recruiting
- Northwestern, Chicago
Transpacific TAVR Registry
RecruitingObservational study
- Northwestern Memorial Hospital, Chicago
About Heart Valve Diseases
Heart valve disease happens when one or more of your heart valves do not open or close correctly. This can affect your blood flow and strain your heart.
More about Heart Valve Diseases on MedlinePlus
Heart Valve Diseases trials in other cities
- New York City, NY11 studies
- Cleveland, OH10 studies
- Phoenix, AZ5 studies
- Minneapolis, MN5 studies
- Cincinnati, OH5 studies
- Atlanta, GA4 studies
- Pittsburgh, PA4 studies
- Houston, TX4 studies
- Philadelphia, PA4 studies
- Boston, MA4 studies
- Thousand Oaks, CA3 studies
- Ann Arbor, MI3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer59 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer36 studies
- Colorectal Cancer34 studies
- Stroke34 studies
- Heart Failure31 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.